Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief Consumer, Medical, Health, Biotech Continue Reading
FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
Parkway Prosthodontics Achieves Breakthrough Full-Arch Reconstruction Case Services, Medical, Health, Technology, Biotech Continue Reading
Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments Business, Society, Medical, Science, Biotech Continue Reading
EPP Pricing Platform announces leadership transition to support long-term growth and continuity Consumer, Retail, Manufacturing, Biotech Continue Reading
Stipenda Appoints David Epstein as Chief Operating Officer Technology, Biotech, Legal, Financial Continue Reading
Metavalis Launches Massive Community Coat Drive in Branson to Support Local Residents Society, Health, Non-profit, Science, Biotech Continue Reading
Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring Business, Medical, Health, Non-profit, Healthcare, Biotech Continue Reading
High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development Business, Finance, Health, Technology, Healthcare, Biotech, Stocks, Artificial Intelligence, Stock Market, Financial, Nasdaq Continue Reading
VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge Finance, Health, Banking, Healthcare, Biotech, Stocks, Stock Market, Financial Continue Reading
High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030 Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets Biotech Continue Reading
FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough Finance, Medical, Health, Marketing, Banking, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading